WeVote
Log In

Bill

PH

Bill

HR 8938

Biotechnology Workforce Alignment Act of 2026

119th Congress Introduced by Pat Harrigan and 3 co-sponsors

Establish a coordinated framework to align federal, education, and industry biotech training and funding, boosting domestic biotech workforce readiness and industry needs.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 8938

Overview

HR 8938, the Biotechnology Workforce Alignment Act of 2026, is a bill introduced in the 119th Congress with the aim of aligning federal programs and investments to strengthen the U.S. biotechnology workforce. It seeks to coordinate training, education, and employer partnerships to build a capable domestic biotech talent pipeline and enhance competitiveness in biotechnology sectors such as healthcare, agriculture, and industrial biotech.

Main purpose and intent

  • Establish a coordinated framework to develop and align the U.S. biotechnology workforce across federal programs, higher education, industry partners, and workforce development initiatives.
  • Improve alignment between education/training pipelines and employer needs to increase job readiness, placement, and career progression in biotech fields.
  • Enhance national capabilities in bioscience research translation, biomanufacturing, and related regulatory and quality systems through a skilled workforce.

Key provisions and changes

  • Coordination and governance: Creates or designates a coordinating mechanism (agency-level or interagency) to align federal workforce development activities related to biotechnology, ensuring coherence across programs and funding streams.
  • Workforce development programs: Streamlines or harmonizes existing grants, apprenticeships, and training programs to focus on biotechnology skills such as laboratory technique, biosafety, bioinformatics, data analysis, quality systems, and bioprocessing.
  • Education and training pathways: Promotes curricula development in colleges, universities, and technical schools to reflect current and anticipated industry needs; supports registered apprenticeships and short-term training for in-demand biotech roles.
  • Public-private partnerships: Encourages collaboration between federal agencies, industry, and academia to identify skills gaps, fund targeted training, and provide work-based learning opportunities.
  • Metrics and accountability: Establishes performance metrics to assess employment outcomes, wage progression, and retention in biotech roles; may require reporting and program evaluations to ensure effectiveness.
  • Equity and access: Addresses opportunities for underrepresented groups and regions to participate in biotechnology education and jobs, potentially including targeted outreach or support for disadvantaged communities.

Who or what would be affected

  • Federal agencies administering workforce development, higher education, and bioscience programs (potentially including the departments of Education, Labor, and Commerce, and related science agencies).
  • Postsecondary institutions, community colleges, and technical training providers involved in biotech education and credentialing.
  • Biotechnology and life sciences employers, research labs, biomanufacturers, and industry associations engaged in training and placement efforts.
  • Students, trainees, and workers seeking biotech-related credentials, apprenticeships, or career advancement opportunities.
  • Regions with growing biotech ecosystems that could benefit from enhanced workforce alignment and investment.

Procedural and timeline aspects

  • Introduction and referral: The bill was introduced in the House and referred to the House Committee on Science, Space, and Technology for consideration.
  • Next steps: The committee may conduct hearings, review, and mark up the bill, with potential amendments before sending it to the House floor for debate and a vote.
  • Implementation timeline: If enacted, the coordinating framework and programs would be implemented according to a specified timeline (not explicitly stated here) with potential phased rollouts tied to funding cycles and performance reporting requirements.

Potential impact

  • Improved alignment between biotech education and industry needs, potentially increasing the number of graduates and trainees entering biotech jobs.
  • Strengthened domestic biotechnologies workforce, supporting innovation, manufacturing capabilities, and national competitiveness.
  • More standardized training and credentialing across programs, which could reduce overlap and inefficiencies in federal investments.
  • Increased emphasis on equity and inclusive access to biotech careers, helping underserved communities participate in biotech growth.

Note: This summary is based on the bill’s title, sponsorship, and action history. For precise language, specific program names, funding levels, and detailed provisions, the bill text and amendments should be consulted.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.